CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Clinical trial NCT05218408 · WITHDRAWN

Trial details

NCT number: NCT05218408
Sponsor: Celularity Incorporated
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Astrocytoma, Grade IV Glioblastoma Giant Cell Glioblastoma Glioblastoma Multiforme

Start date: 2021-09-01
Primary completion: 2021-10-23
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.